Royal Capital Wealth Management, LLC Anavex Life Sciences Corp. Transaction History

Royal Capital Wealth Management, LLC

  • $124 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
BUY
$7.31 - $12.84 $2,924 - $5,136
400 Added 2.21%
18,500 $185,000
Q1 2022

May 12, 2022
BUY
$9.74 - $17.69 $15,584 - $28,304
1,600 Added 9.7%
18,100 $223,000
Q4 2021

Feb 15, 2022
BUY
$16.88 - $23.31 $278,520 - $384,615
16,500 New
16,500 $286,000

Others Institutions Holding AVXL

# of Institutions
159
Shares Held
31.6M
Call Options Held
910K
Put Options Held
1.35M
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $352M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Royal Capital Wealth Management, LLC Portfolio

Follow Royal Capital Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Capital Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Capital Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email